ESC 365 - Novel risk model for predicting acute adverse drug reactions following cardiac catheterization from TRUST study (the safety and tolerability of ultravist in patients undergoing cardiac catheterization

ESC Premium Access

Novel risk model for predicting acute adverse drug reactions following cardiac catheterization from TRUST study (the safety and tolerability of ultravist in patients undergoing cardiac catheterization

Session: Poster Session 5 - Coronary artery disease - Diagnosis, pharmacotherapy and revascularisation 2

Topic: Prevention

Speaker: Doctor Y. Liu (Guangzhou, CN)

Event: ESC Congress 2018

Congress Presentation

Add to my library

About the speaker

Doctor Yong Liu

Guangdong General Hospital Guangdong Cardiovascular Institute, Guangzhou (China)

0 follower

9 more presentations in this session

Network meta-analysis comparing iFR vs. FFR vs. coronary angiography to drive coronary revascularization

Speaker: Doctor F. Fioravanti (Milan, IT)

Chronic total occlusion represents an independent predictor for mortality in malignant arrhythmias and sudden cardiac death

Speaker: Doctor I. El-Battrawy (Bochum, DE)

Evaluation of safety and efficacy of sirolimus eluating coronary stent yukon choice flex in all comer coronary artery disease patients a single center experience

Speaker: Doctor S. Kasturi (Hyderabad, IN)

Calcifications as an indicator for an NIRS-based risk profile of coronary atherosclerotic plaques.

Speaker: Ms E. Hartman (Rotterdam, NL)

Referral of patients for fractional flow reserve using quantitative flow ratio

Speaker: Mr J. Smit (Leiden, NL)

Access the full session

Poster Session 5 - Coronary artery disease - Diagnosis, pharmacotherapy and revascularisation 2

Speakers: Doctor Y. Liu, Doctor F. Fioravanti, Doctor I. El-Battrawy, Doctor S. Kasturi, Ms E. Hartman...

About the event

ESC Congress 2018

25 August - 29 August 2018

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources